# Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO

> **NCT05413720** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de la Réunion** · enrollment: 100 (actual)

## Conditions studied

- Leptospirosis

## Interventions

- **OTHER:** two additional blood samples specific to research

## Key facts

- **NCT ID:** NCT05413720
- **Lead sponsor:** Centre Hospitalier Universitaire de la Réunion
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-06
- **Primary completion:** 2022-07-20
- **Final completion:** 2022-07-20
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05413720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05413720, "Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05413720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*